Clincosm LogoSign in Get a demo

male breast carcinoma

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in United States

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +4 more
  • Bevacizumab
  • +5 more
  • Jonesboro, Arkansas
  • +452 more
Jan 13, 2023

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Tucson, Arizona
  • +317 more
Mar 1, 2022

Male Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (biological,

Completed
Has Results
  • Male Breast Carcinoma
  • +2 more
  • Cixutumumab
  • +3 more
  • Palo Alto, California
  • +191 more
May 15, 2018

Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma Trial in Seattle (drug, procedure, other)

Completed
Has Results
  • Estrogen Receptor Positive
  • +9 more
  • Fluorothymidine F-18
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 13, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 29, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,

Completed
  • Estrogen Receptor Negative
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Bronx, New York
  • +5 more
Dec 21, 2017

Estrogen Receptor Positive, Male Breast Carcinoma, Progesterone Receptor Positive Trial in Detroit (Laboratory Biomarker

Completed
Has Results
  • Estrogen Receptor Positive
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Detroit, Michigan
  • +1 more
Oct 27, 2017

Adult Solid Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Scottsdale, Jacksonville, Rochester (Cilengitide,

Completed
  • Adult Solid Neoplasm
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Mar 14, 2016

Adult Solid Tumor, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Hershey, Pittsburgh (Carboplatin, Laboratory

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Hershey, Pennsylvania
  • +2 more
May 22, 2015

Estrogen Receptor Positive, HER2/Neu Negative, Male Breast Carcinoma Trial in United States (Exemestane, Gamma-Secretase

Terminated
  • Estrogen Receptor Positive
  • +6 more
  • Tampa, Florida
  • +3 more
May 22, 2015

Adult Solid Tumor, Inflammatory Breast Carcinoma, Male Breast Carcinoma Trial in United States (Capecitabine, Docetaxel,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Scottsdale, Arizona
  • +6 more
May 1, 2015

Male Breast Carcinoma, Recurrent Breast Carcinoma, Stage IA Breast Cancer Trial in New Brunswick (drug, procedure, other)

Terminated
  • Male Breast Carcinoma
  • +6 more
  • Pazopanib Hydrochloride
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Mar 24, 2015